Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT
Authors
Keywords
-
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-28
DOI
10.1007/s00432-021-03618-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exosomal ephrinA2 derived from serum as a potential biomarker for prostate cancer
- (2018) Shibao Li et al. Journal of Cancer
- Prognostic role of N-cadherin expression in patients with non–muscle-invasive bladder cancer
- (2017) Mohammad Abufaraj et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition
- (2016) Jinfeng Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer
- (2015) Shibao Li et al. TUMOR BIOLOGY
- PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis
- (2015) Zeyad D Nassar et al. Oncotarget
- Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening
- (2014) Robert A. Smith et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Eph/Ephrin family in cancer metastasis: communication at the service of invasion
- (2012) Mustapha Kandouz CANCER AND METASTASIS REVIEWS
- The EMT signaling pathways in endometrial carcinoma
- (2012) Eva Colas et al. Clinical & Translational Oncology
- Vimentin in cancer and its potential as a molecular target for cancer therapy
- (2011) Arun Satelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Overexpression of EphA2 correlates with epithelial–mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients
- (2011) Futao Hou et al. MEDICAL ONCOLOGY
- Re-Expression of AKAP12 Inhibits Progression and Metastasis Potential of Colorectal Carcinoma In Vivo and In Vitro
- (2011) Weiwei Liu et al. PLoS One
- Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies
- (2010) Guy Lahat et al. PLoS One
- Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway
- (2009) Yu-Xiong Feng et al. HEPATOLOGY
- SSeCKS/Gravin/AKAP12 Inhibits Cancer Cell Invasiveness and Chemotaxis by Suppressing a Protein Kinase C- Raf/MEK/ERK Pathway
- (2009) Bing Su et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EphA2 Engages Git1 to Suppress Arf6 Activity Modulating Epithelial Cell–Cell Contacts
- (2009) Koichi Miura et al. MOLECULAR BIOLOGY OF THE CELL
- Expression of EphA2 and E-cadherin in Gastric Cancer: Correlated with Tumor Progression and Lymphogenous Metastasis
- (2009) Weijie Yuan et al. PATHOLOGY & ONCOLOGY RESEARCH
- Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism
- (2008) W. B. Fang et al. JOURNAL OF CELL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started